Posted on 9/1/20
Theator Partners with Tel Aviv Sourasky Medical Center
Theator, the Surgical Intelligence platform leveraging advanced AI and computer vision to improve surgeon performance, today announced a new partnership with Tel Aviv Sourasky Medical Center . . .
Posted on 9/1/20
HPOne and FDS Announce Strategic Partnership
HealthPlanOne, Inc. and FDS, Inc. announced today that they have formed a strategic partnership to provide support for pharmacies using the FDS platform and their patients seeking . . .
Posted on 9/1/20
Aetna and Landmark Health Partner
EW YORK--(BUSINESS WIRE)--Aetna, a CVS Health company (NYSE: CVS), and Landmark Health and its affiliated medical groups (Landmark) announced today a new relationship to bring physician-led . . .
Posted on 9/1/20
Aptorum Group Limited Reports Financial Results and Business Update
NEW YORK--(BUSINESS WIRE)--Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM), a biopharmaceutical company focuses on the development of novel therapeutics to address global unmet medical needs, . . .
Posted on 8/31/20
NYS Report Ranks Northwell Among Best for Cardiac Surgery
NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--A newly released New York State (NYS) Department of Health (DOH) report showed Northwell Health’s Sandra Atlas Bass Heart Hospital at North . . .
Posted on 8/31/20
Aphex BioCleanse Systems Enters Agreement with Now Biopharma
Aphex BioCleanse Systems, Inc. (OTC: SNST), a sanitization solutions company focused on the development and distribution of chemical-free, water-based sanitization and disinfection products, announced today that . . .
Posted on 8/31/20
Conversion Labs Receives Commitment for $3.5 Million Equity Investment from Strategic Investors
NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, announced that a select group of private . . .
Posted on 8/31/20
In the Race for a Coronavirus Vaccine, Can There Be Multiple Winners?
Everyone is wondering which company will win the race to produce a coronavirus vaccine. With 31 candidates in clinical development and six of those in phase . . .
Posted on 8/31/20
Has The COVID-19 Vaccine Stock Bubble Burst?
COVID-19 vaccine stocks have easily been the hottest niche across the entire market since March. Developmental-stage companies like Inovio Pharmaceuticals (NASDAQ:INO), Moderna (NASDAQ:MRNA), Novavax (NASDAQ:NVAX), Vaxart . . .
Posted on 8/31/20
Better Buy: Eli Lilly vs. Pfizer
Eli Lilly (NYSE:LLY) and Pfizer (NYSE:PFE) are two of several pharma giants in the race to combat COVID-19. Eli Lilly is currently evaluating three potential therapies . . .
Posted on 8/31/20
Is Quest Diagnostics a Great Dividend Stock?
To me, a great dividend stock means an investment that pays a good yield today and is likely to increase it going forward, with payouts that . . .
Posted on 8/31/20
Fortress Biotech Prices Series A Preferred Stock Offering
NEW YORK, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Common Stock: Nasdaq: FBIO) (Preferred Stock: Nasdaq: FBIOP), an innovative biopharmaceutical company, today announced that . . .
Posted on 8/31/20
Fortress Biotech Announces $60M Loan Agreement with Oaktree Capital Management
NEW YORK, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO), an innovative revenue-generating company focused on acquiring, developing and commercializing or monetizing promising . . .
Posted on 8/31/20
Northern Westchester Hospital Opens $3.6M Comprehensive Cardiac Catheterization Lab
Ribbon cutting at Cardiac Cath Lab. (L-R): Carl Dietrich Reimers, MD; A. Garvey Rene, MD; Northern Westchester Hospital executive director Derek Anderson; Seema Boesky; Scott D. Hayworth, MD, . . .
Posted on 8/28/20
Pharmaceutical Investments to Purchase During the COVID-19 Crisis
Pharmaceutical investments to purchase during the COVID-19 crisis include two traditional industry giants and an exchange-traded fund (ETF) that offers exposure to stocks that are pursuing . . .
Posted on 8/28/20
Fortress Biotech Announces $60 Million Loan Agreement with Oaktree Capital Management
NEW YORK, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO), an innovative revenue-generating company focused on acquiring, developing and commercializing or monetizing promising . . .
Posted on 8/28/20
Pfizer Is Out, Honeywell Is In: Should The Dow Jones Shake-Up Change Your Investing Strategy?
Three of the 30 stocks that make up the Dow Jones Industrial Average will be replaced at the end of this month. Standard & Poor's, which . . .
Posted on 8/27/20
Long Island Plastic Surgical Group Appoints David Mattos
Garden City, NY, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Long Island Plastic Surgical Group (LIPSG), the largest private plastic and reconstructive surgery practice in the United . . .
Posted on 8/27/20
NanoVibronix Closes $3.4M Bought Deal Offering
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, announced . . .
Posted on 8/27/20
Parker Health Group Teams Up with AARP Foundation
Parker Health Group Inc. (parkerlife.org) has provided a grant of $170,000 to AARP Foundation to implement Connect2Affect Connected Communities in 13 New Jersey affordable senior housing . . .
Posted on 8/27/20
3 Green Flags for Pfizer's Future
COVID-19 is both contagious and deadly, and when a vaccine becomes available, billions of people worldwide may need to take it if economies are to reopen . . .
Posted on 8/27/20
Pfizer Says It Has Over 50% Enrollment for Coronavirus Vaccine Candidate Trial
One of the leading COVID-19 vaccine candidates currently in development is getting closer to a potential finish line. Pfizer (NYSE:PFE) said on Wednesday that the recruitment . . .
Posted on 8/27/20
Better Buy: CVS vs. Regeneron
Coming into 2020, there's no question that you would have been better off investing in Regeneron Pharmaceuticals (NASDAQ:REGN) than in CVS (NYSE:CVS). If you had spent . . .
Posted on 8/26/20
Royalty Pharma Prices $6B Senior Unsecured Notes
NEW YORK, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma plc announced today that it has priced an offering of $6 billion senior unsecured notes, comprised . . .
Posted on 8/26/20
Ovid Therapeutics Prices $50M Offering of Common Stock
NEW YORK, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of patients . . .
New York
